Med-Tech Fits This Market Moment

So many in this group reporting such great numbers tells you that these stocks work in precisely this environment.
Author:
Publish date:

This column was originally published on RealMoney on July 20 at 11:01 a.m. EDT.

The tug of war goes to med-tech again today, as

St. Jude

(STJ)

and

Stryker

(SYK) - Get Report

join the hit parade.

Not for a moment do I want to suggest that you need to back away from tech. We are getting a gift with the

downgrade of

Seagate

(STX) - Get Report

this morning. I believe you could see some excellent numbers coming from

Broadcom

(BRCM)

off the extraordinary

Motorola

(MOT)

number.

But you have to sit up and take notice of this med-tech segment. It's extraordinary that so many of these companies are reporting so many good numbers. It tells you that the opportunities are fantastic and are perfect for this environment, given that the

Fed

Chairman is on the tape telling you he isn't done choking off the economy. These stocks work in precisely this environment.

Image placeholder title

Amgen

(AMGN) - Get Report

,

Genentech

(DNA)

, St. Jude, Stryker -- I believe they all work, and will work much better than anything else this session.

P.S. from TheStreet.com Editor-in-Chief, Dave Morrow:

It's always been my opinion that it pays to have more -- not fewer -- expert market views and analyses when you're making investing or trading decisions. That's why I recommend you take advantage of our

free trial offer

to TheStreet.com

RealMoney

premium Web site, where you'll get in-depth commentary

and

money-making strategies from over 50 Wall Street pros, including Jim Cramer. Take my advice --

try it now.

At the time of publication, Cramer was long Motorola.

James J. Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here. Listen to Cramer's RealMoney Radio show on your computer; just click

here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click

here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict."